Is EINECS 257-232-2 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EINECS 257-232-2? Is EINECS 257-232-2 safe for nursing mother and child? Does EINECS 257-232-2 extracts into breast milk? Does EINECS 257-232-2 has any long term or short term side effects on infants? Can EINECS 257-232-2 influence milk supply or can EINECS 257-232-2 decrease milk supply in lactating mothers?
EINECS 257-232-2 lactation summary
- DrLact safety Score for EINECS 257-232-2 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of EINECS 257-232-2 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that EINECS 257-232-2 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of EINECS 257-232-2 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using EINECS 257-232-2 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EINECS 257-232-2 usage in lactation
No long-term adverse effects have been reported. However, it is excreted in large amounts into breast milk. American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding.
Answer by DrLact: About EINECS 257-232-2 usage in lactation
Limited information indicates that maternal EINECS 257-232-2 results in infant dosages much less than those given directly to neonates. EINECS 257-232-2 would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. However, because of its potential for causing hepatic enzyme inhibition, other drugs might be preferred.
EINECS 257-232-2 Possible Effects in Breastfeeding
Histamine H2-receptor blockade is known to stimulate prolactin secretion. In addition, EINECS 257-232-2 may have additional, nonspecific actions that stimulate prolactin secretion.[2] Oral EINECS 257-232-2 doses of 400 mg 4 times daily increased serum prolactin by 50 to 112% in 6 patients. EINECS 257-232-2 caused dose-related gynecomastia and galactorrhea in men and nonnursing women.[3][4][5] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs
Cimetidine(Low Risk)
Dexlansoprazole(Safe)
Lansoprazole(Safe)
Esomeprazole(Safe)
Misoprostol(Safe)
Ranitidine(Safe)
Omeprazole(Safe)
Sucralfate(Safe)
Nizatidine(Safe)
Rabeprazole(Safe)
Famotidine(Safe)
Pantoprazole(Safe)
Dexlansoprazole(Safe)
Lansoprazole(Safe)
Doxylamine(Unsafe)
Infliximab(Safe)
Magnesium Oxide(Safe)
Docusate(Safe)
Thiethylperazine(Unsafe)
Cisapride(Safe)
Esomeprazole(Safe)
Sodium Picosulfate(Safe)
Cascara Sagrada(Low Risk)
Prochlorperazine(Unsafe)
Misoprostol(Safe)
Ranitidine(Safe)
Etanercept(Safe)
Rifaximin(Safe)
Bisacodyl(Safe)
Dimenhydrinate(Low Risk)
Adalimumab(Safe)
Domperidone(Safe)
Omeprazole(Safe)
Peppermint(Safe)
Sulfasalazine(Safe)
Ursodiol(Safe)
Nizatidine(Safe)
Cyclizine(Low Risk)
Olsalazine(Safe)
Sucralfate(Safe)
Octreotide(Safe)
Mesalamine(Safe)
Alosetron(Low Risk)
Loperamide(Safe)
Trimethobenzamide(Unsafe)
Senna(Safe)
Famotidine(Safe)
Rabeprazole(Safe)
Metoclopramide(Safe)
Certolizumab Pegol(Safe)
Pantoprazole(Safe)
Linaclotide(Safe)
Magnesium Sulfate(Safe)
Cimetidine(Low Risk)
Droperidol(Low Risk)
Magnesium Hydroxide(Safe)
Cimetidine(Low Risk)
Ranitidine(Safe)
Nizatidine(Safe)
Famotidine(Safe)